Maser Raelene E, Mitchell Braxton D, Vinik Aaron I, Freeman Roy
Department of Medical Technology, University of Delaware, Newark, Delaware 19716, USA.
Diabetes Care. 2003 Jun;26(6):1895-901. doi: 10.2337/diacare.26.6.1895.
To examine by meta-analysis the relationship between cardiovascular autonomic neuropathy (CAN) and risk of mortality in individuals with diabetes.
We searched Medline for English-language articles published from 1966 to 2001. Fifteen studies having a baseline assessment of cardiovascular autonomic function and mortality follow-up were identified. The analyses were stratified according to whether a single abnormality or two or more measures of cardiovascular autonomic function were used to define CAN. A global measure of association (i.e., relative risk) was generated for each group by pooling estimates across the studies using the Mantel-Haenszel procedure.
CAN was significantly associated with subsequent mortality in both groups, although the magnitude of the association was stronger for those studies for which two or more measures were used to define CAN. The pooled relative risk for studies that defined CAN with the presence of two or more abnormalities was 3.45 (95% CI 2.66-4.47; P < 0.001) compared with 1.20 (1.02-1.41; P = 0.03) for studies that used one measure.
These results support an association between CAN and increased risk of mortality. The stronger association observed in studies defining CAN by the presence of two or more abnormalities may be due to more severe autonomic dysfunction in these subjects or a higher frequency of other comorbid complications that contributed to their higher mortality risk. Future studies should evaluate whether early identification of subjects with CAN can lead to a reduction in mortality.
通过荟萃分析研究心血管自主神经病变(CAN)与糖尿病患者死亡风险之间的关系。
我们检索了Medline中1966年至2001年发表的英文文章。确定了15项对心血管自主神经功能进行基线评估并随访死亡率的研究。根据是否使用单一异常或两种或更多种心血管自主神经功能测量方法来定义CAN对分析进行分层。通过使用Mantel-Haenszel程序汇总各项研究的估计值,为每组生成一个总体关联度量(即相对风险)。
两组中CAN均与随后的死亡率显著相关,尽管对于使用两种或更多种测量方法定义CAN的那些研究,关联程度更强。对于使用两种或更多种异常情况来定义CAN的研究,汇总相对风险为3.45(95%可信区间2.66 - 4.47;P < 0.001),而使用一种测量方法的研究为1.20(1.02 - 1.41;P = 0.03)。
这些结果支持CAN与死亡风险增加之间存在关联。在通过两种或更多种异常情况定义CAN的研究中观察到的更强关联,可能是由于这些受试者的自主神经功能障碍更严重,或者是其他合并症并发症的发生率更高,导致其死亡风险更高。未来的研究应评估早期识别CAN患者是否能降低死亡率。